{"organizations": [], "uuid": "e65304e7b08b44eb52bd7243d7aeb1dd21f18d0d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-arms-medical-and-tissue-regenix-bi/brief-arms-medical-and-tissue-regenix-biosurgery-sign-exclusive-distributor-agreement-idUSFWN1QG14W", "country": "US", "domain_rank": 408, "title": "BRIEF-ARMS Medical And Tissue Regenix BioSurgery Sign Exclusive Distributor Agreement", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-26T18:13:00.000+02:00", "replies_count": 0, "uuid": "e65304e7b08b44eb52bd7243d7aeb1dd21f18d0d"}, "author": "", "url": "https://www.reuters.com/article/brief-arms-medical-and-tissue-regenix-bi/brief-arms-medical-and-tissue-regenix-biosurgery-sign-exclusive-distributor-agreement-idUSFWN1QG14W", "ord_in_thread": 0, "title": "BRIEF-ARMS Medical And Tissue Regenix BioSurgery Sign Exclusive Distributor Agreement", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters staff", "sentiment": "none"}, {"name": "reuters) - tissue regenix group plc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 26, 2018 / 4:13 PM / Updated 5 minutes ago BRIEF-ARMS Medical And Tissue Regenix BioSurgery Sign Exclusive Distributor Agreement Reuters Staff 1 Min Read Feb 26 (Reuters) - Tissue Regenix Group Plc: * ARMS MEDICAL AND TISSUE REGENIX BIOSURGERY SIGN EXCLUSIVE DISTRIBUTOR AGREEMENT FOR DERMAPURE® ALLOGRAFT WITH DCELL® TECHNOLOGY * ‍ARMS MEDICAL SAYS DEAL GIVES CO EXCLUSIVE RIGHTS TO DISTRIBUTE TISSUE REGENIX BIOLOGIC THROUGHOUT U.S. FOR USE IN UROLOGY & GYNECOLOGY PROCEDURES​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-26T18:13:00.000+02:00", "crawled": "2018-02-26T18:30:06.000+02:00", "highlightTitle": ""}